Patents by Inventor Chi-Kin Chow

Chi-Kin Chow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ELECTRICALLY CONNECTING ELEMENT AND PHOTOVOLTAIC MODULE
    Publication number: 20130008481
    Abstract: Disclosed herein is an electrically connecting element, which comprises a thin-film photovoltaic cells and an electrically connecting element disposed on a back surface of the film photovoltaic cells. The electrically connecting element comprises a conductive wire and an insulating wrapper wrapped around the conductive wire. The conductive wire has two ends and a bonding portion positioned therebetween. The insulating wrapper has a notch exposing the bonding portion. The two ends extend out of the insulating wrapper. At least one of the two ends is in contact with a bus electrode of the film photovoltaic cells, and the bonding portion is in contact with another bus electrode of the film photovoltaic cells.
    Type: Application
    Filed: July 8, 2011
    Publication date: January 10, 2013
    Applicant: Du Pont Apollo Limited
    Inventors: Chi-Kin CHOW, Yang-Yang Zhou, Hsieh-Hsin Yeh
  • Anti-IL-17 antibodies
    Patent number: 8110191
    Abstract: Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.
    Type: Grant
    Filed: October 21, 2010
    Date of Patent: February 7, 2012
    Assignee: Eli Lilly and Company
    Inventors: Barrett Allan, Chi-Kin Chow, Ling Liu, Jirong Lu, Jonathan Wendell Tetreault, Ying Tang
  • ANTI-IL-17 ANTIBODIES
    Publication number: 20110027290
    Abstract: Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.
    Type: Application
    Filed: October 21, 2010
    Publication date: February 3, 2011
    Applicant: ELI LILLY AND COMPANY
    Inventors: Barrett Allan, Chi-Kin Chow, Ling Liu, Jirong Lu, Jonathan Wendell Tetreault
  • Anti-IL-17 antibodies
    Patent number: 7838638
    Abstract: Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: November 23, 2010
    Assignee: Eli Lilly and Company
    Inventors: Barrett Allan, Chi-Kin Chow, Ling Liu, Jirong Lu, Jonathan Wendell Tetreault
  • PEGYLATED ABETA FAB
    Publication number: 20100015155
    Abstract: A method to treat conditions associated with A? peptide activity both prophylactically and therapeutically is described. The method employs humanized antibody fragments that specifically bind human A? peptide between amino acid positions 13-28, wherein the antibody fragments are covalently attached to a polyethylene glycol (PEG) molecule.
    Type: Application
    Filed: January 9, 2008
    Publication date: January 21, 2010
    Inventors: Kelly Renee Bales, Thomas Frank Bumol, Chi-Kin Chow, Ronald Bradley Demattos, Ryan John Hansen, Uma Kuchibhotla, Jirong Lu, Peter Colon McDonnell
  • Anti-IL-17 Antibodies
    Publication number: 20080269467
    Abstract: Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.
    Type: Application
    Filed: December 5, 2006
    Publication date: October 30, 2008
    Inventors: Barrett Allan, Chi-Kin Chow, Lihua Huang, Ling Liu, Jirong Lu, Kingman Ng, Jonathan Wendell Tetreault, Andrew Gordon Werner